Drugs / allogeneic islet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06751199 | Dec 2024 → Jul 2026 overdue | diabetes mellitus | Shanghai Changzheng Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allogeneic islet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06751199 ↗ |
| Modality | Cell therapy | “allogeneic islet transplantation” NCT06751199 ↗ |
| Route | Other | “Portal vein infusion of allogeneic islet” NCT06751199 ↗ |